Alternatives to Cortisone Injections in Seattle, WA

CDC PLACES vs. JF: two files, not one brochure

Seattle is a city of 500k–1M (749,256 Census). CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Adult arthritis here is 17% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 17% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 6.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Washington.
• In a city of 500k–1M, vendor noise is the operational problem: too many look-alike allograft flyers, too little chain-of-custody paperwork. Hawk Medical ships nationwide with HCT/P documentation; we do not invent a Seattle street address.
• Skin-substitute and CTP coverage has been rewritten multiple times at the MAC level. Washington practices billing Noridian Healthcare Solutions need current LCD/article IDs on the claim, not a distributor slogan about “advanced wound care.”

What CDC PLACES and JF each actually tell you

JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Seattle is 6.1% or not. PLACES is planning data. The LCD is the claim.

Before the first cortisone injection alternatives shipment